News & Events 2013

December Newsletter - Health Outcomes Research & Alternative Data Collection Methods

December 31, 2013

Read More

CTI Clinical Trial and Consulting Services Announces David Facklam, MS has joined as Senior Director, Regulatory and Scientific Affairs

December 10, 2013

CTI Clinical Trial and Consulting Services (CTI) announces David Facklam, MS has joined as Senior Director, Regulatory and Scientific Affairs. Mr. Facklam has over 30 years of experience in clinical drug development in the pharmaceutical industry. Prior to joining CTI, Mr. Facklam held positions of increasing responsibility in the ...

Read More

CTI Clinical Trial & Consulting Services will attend the American Society of Hematology (ASH) Annual Meeting December 7–10, 2013

December 7, 2013

The meeting is taking place in New Orleans, LA. If you will be attending, please contact us to schedule a meeting!

Read More

November Newsletter - CTI's View of Risk-Based Approach to Monitoring

November 30, 2013

Read More

CTI Clinical Trial and Consulting Services Announces William Aronstein, PhD, MD, FACP has been promoted to Vice President, Medical Affairs

November 20, 2013

CTI Clinical Trial and Consulting Services (CTI) announces William Aronstein, PhD, MD, FACP has been promoted to Vice President, Medical Affairs. Dr. Aronstein has vast experience in early phase clinical development, including protocol development, execution, and analysis, as well as over 30 years of clinical, academic, and industry experience. ...

Read More

CTI Clinical Trial and Consulting Services to Sponsor and Participate in 6th Annual Blue Ash Life Sciences Collaborative

October 30, 2013

CTI Clinical Trial and Consulting Services (CTI) announces Timothy J. Schroeder, Chief Executive Officer, will participate in the 6th Annual Blue Ash Life Sciences Collaborative, taking place October 31, 2013 in Blue Ash, Ohio. CTI is also a proud sponsor of the event. Mr. Schroeder will moderate the Industry ...

Read More

CTI Clinical Trial and Consulting Services Announces Launch of S2 Hospital Insights Database

October 21, 2013

CTI Clinical Trial and Consulting Services (CTI)’s newly expanded department, S2 Health Economics Outcomes Research (S2 HECOR), announces the launch of S2 Hospital Insights, an innovative web-based tool that provides a look at definitive hospital reimbursement data. With this exclusive information, pharmaceutical, biotechnology, and medical device companies, along with healthcare ...

Read More

CTI Clinical Trial and Consulting Services CEO, Timothy J. Schroeder, to participate in panel discussion at the 2013 Stem Cell Meeting on the Mesa

October 11, 2013

CTI Clinical Trial and Consulting Services (CTI) announces Timothy J. Schroeder, Chief Executive Officer, will participate in a panel discussion at the 2013 Stem Cell Meeting on the Mesa, taking place October 14-16, 2013 in La Jolla, California. The meeting brings together members of the scientific research community and those ...

Read More

October Newsletter - FDA Breakthrough Designation

October 1, 2013

Read More

CTI Clinical Trial and Consulting Services Announces Timothy J. Schroeder, Chief Executive Officer, to Present at 2013 SPLIT Annual Meeting

September 25, 2013

CTI Clinical Trial and Consulting Services (CTI) announces Timothy J. Schroeder, Chief Executive Officer, will present at the 2013 Studies in Pediatric Liver Transplantation (SPLIT) Annual Meeting, taking place September 26-27, 2013 in Toronto. Mr. Schroeder will present on the topic “The Challenges of Designing and Implementing Clinical Trials: ...

Read More

CTI Clinical Trial and Consulting Services Announces that Edward A. Kouche III, CPA has joined as Director, International Accounting and Finance

September 16, 2013

CTI Clinical Trial and Consulting Services (CTI) announces the hiring of Edward A. Kouche III, CPA as Director, International Accounting and Finance.Ed comes to CTI from INC Research (formerly Kendle International), where he worked for nearly 15 years. Throughout his time there, he served as International Controller, Corporate Controller, and ...

Read More

CTI Clinical Trial and Consulting Services Announces the Formation of Italian Subsidiary and Opens Office in Milan, Italy

September 9, 2013

CTI Clinical Trial and Consulting Services (CTI) announces that it has opened an office in Milan, Italy. The office is opened through its newly created wholly-owned subsidiary, CTI Clinical Trial and Consulting Services Italy, S.R.L. “We believe that the market for clinical research is continuing its growth throughout Europe, ...

Read More

September Newsletter - A Reflection on CTI's 15th Anniversary

September 1, 2013

Read More

CTI Clinical Trial and Consulting Services Announces that Maria Marsh has been Named a Finalist for CFO of the Year

August 30, 2013

CTI Clinical Trial and Consulting Services (CTI) announces that Maria Marsh, Chief Financial Officer and Vice President at CTI, was named the Cincinnati Business Courier’s 2013 CFO of the Year. Maria was honored, along with the 21 other finalists of various Greater Cincinnati organizations, at the award ceremony on Thursday, ...

Read More

CTI Clinical Trial and Consulting Services Awarded 2013 Goering Center Private Business Award

August 28, 2013

CTI Clinical Trial and Consulting Services (CTI) was awarded the 2013 Goering Center Private Business Award. CTI was presented the award at the 14th annual ceremony, which took place August 27, 2013.The Goering Center recognized finalists and category winners for their success in family and private business. An independent panel ...

Read More

CTI Clinical Trial and Consulting Services Announces that Dr. Ralph Campaneria has joined as Medical Director

August 13, 2013

Prior to joining CTI, Dr. Campaneria was with Inhibitex, a biopharmaceutical company, where he served as Medical Director, and led the development of several Hepatitis C programs. Dr. Campaneria also spent nearly ten years in multiple roles at Monitoring Force, an international Clinical Research Organization (CRO), conducting Phase II, III, ...

Read More

CTI Clinical Trial and Consulting Services Announces that Thomas Winrod, RN has joined as Associate Director, Clinical Trials and Paula Ulsh, RN, BSN has joined as Assistant Director, Medical and Scientific Affairs

August 7, 2013

CTI Clinical Trial and Consulting Services announces the hiring of Tom Winrod and Paula Ulsh. Thomas Winrod, RN, has joined as Associate Director, Clinical Trials Tom has been in healthcare for over 25 years in both patient care and clinical research. Tom comes to CTI from INC Research ...

Read More

August Newletter - Pediatric Priority Review Voucher

August 1, 2013

Read More

July Newsletter - S2 Statistical Solutions Combining Forces with CTI

July 1, 2013

Read More

CTI Clinical Trial and Consulting Services to Present, Chair and Exhibit at DIA 2013 49th Annual Meeting

June 19, 2013

CTI Clinical Trial and Consulting Services (CTI), an international, privately held, full-service contract research organization will present, chair, and exhibit at the DIA 2013 49th Annual Meeting, Advancing Therapeutic Innovation and Regulatory Science, in Boston, June 23-37. CTI’s Ryan Gifford, Senior Manager, will chair the session “Utilizing Electronic Medical ...

Read More

CTI Clinical Trial and Consulting Services Announces Acquisition of S2 Statistical Solutions

June 12, 2013

CTI Clinical Trial and Consulting Services (CTI), a global, privately held, full-service contract research organization announces the acquisition of S2 Statistical Solutions (S2). S2, a renowned health outcomes and health economics organization, focuses on the power of analytics through data mining and economic research. S2 specializes in generating and interpreting ...

Read More

CTI Clinical Trial and Consulting Services Announces Collaboration with Galectin Therapeutics on Novel Phase I NASH Clinical Trial

June 6, 2013

CTI Clinical Trial and Consulting Services (CTI) announces its collaboration with Galectin Therapeutics on a first-in-man Phase I clinical trial that will support a proposed indication of GR-MD-02 for treatment of non-alcoholic steatohepatitis (NASH or fatty liver disease) with advanced fibrosis.The Phase 1 Clinical Trial is entitled, "A Multi-Center, Partially ...

Read More

June Newsletter - Clinical Trial Considerations - US vs EU

June 1, 2013

Read More

CTI Clinical Trial and Consulting Services Announces the Formation of Polish Subsidiary and Opens Office in Warsaw

May 13, 2013

CTI Clinical Trial and Consulting Services (CTI) announces that is has opened an office in Warsaw, Poland. The office is opened through its newly created wholly-owned subsidiary, CTI Clinical Trial and Consulting Services Poland, sp. z o.o.“Poland, the sixth largest country in Europe, has both a highly educated population and ...

Read More

May Newsletter - The Case for Continued Drug Development in Solid Organ Transplantation

May 1, 2013

Read More

CTI Clinical Trial and Consulting Services President and CEO, Timothy J. Schroeder, to Present at Oracle’s 8th Annual Health Sciences Innovation Forum

April 15, 2013

Timothy J. Schroeder, President and CEO of CTI Clinical Trial and Consulting Services (CTI) will present at Oracle’s 8th Annual Health Sciences Innovation Forum, taking place April 18, 2013 in Parsippany, New Jersey. The forum will explore and discuss the evolving requirements of the health sciences industry.Mr. Schroeder will present ...

Read More

Galectin Therapeutics provides details on first-in-man Phase 1 clinical trial of GR-MD-02

April 10, 2013

Galectin Therapeutics (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, announced details today on its first-in-man Phase 1 clinical trial that will support a proposed indication of GR-MD 02 for treatment of non-alcoholic steatohepatitis (NASH, or fatty liver disease) with advanced fibrosis. ...

Read More

April Newsletter - Role of Clinical Trials in Gene Therapy

April 1, 2013

Read More

CTI Clinical Trial and Consulting Services Joins Alliance for Regenerative Medicine

March 26, 2013

CTI Clinical Trial and Consulting Services (CTI) has joined the Alliance for Regenerative Medicine (ARM), an advocacy organization that promotes legislative, regulatory and reimbursement initiatives necessary to facilitate access to life-giving advances in regenerative medicine. According to their website, “ARM also works to increase public understanding of the field and ...

Read More

March Newsletter - The Value of a Successful Pre-IND Meeting

March 1, 2013

Read More

CTI Clinical Trial and Consulting Services to Sponsor the 8th Annual New York Stem Cell Summit and President and CEO, Timothy J. Schroeder to Present

February 11, 2013

CTI Clinical Trial and Consulting Services (CTI) will be one of the sponsors of the 8th Annual New York Stem Cell Summit, taking place February 19, 2013. The faculty will include more than 30 of the world’s leaders in this industry to lead discussions on investment opportunities, groundbreaking products, and ...

Read More

CTI Clinical Trial and Consulting Services Announces Expanded Capabilities in Global Drug Safety Processing and Reporting with Oracle® Argus Safety 7.1

February 1, 2013

CTI Clinical Trial and Consulting Services (CTI) announces its expanded capabilities in global drug processing and reporting services with the addition of Oracle® Argus Safety 7.1. Oracle® Argus Safety 7.1 is used to capture and process drug safety information from clinical studies and from drug products in the pre-clinical and ...

Read More

February Newsletter - Pediatrics: An Underserved Population in Clinical Research

February 1, 2013

Read More

January Newsletter - CRA Site Survey

January 1, 2013

Read More

Join Our Mailing List